BI Asset Management Fondsmaeglerselskab’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-368
Closed -$120K 762
2024
Q1
$120K Buy
+368
New +$90.3K ﹤0.01% 658
2023
Q3
Sell
-9,228
Closed -$2.63M 779
2023
Q2
$2.63M Sell
9,228
-4,361
-32% -$1.21M 0.06% 219
2023
Q1
$2.95M Buy
13,589
+2,610
+24% +$509K 0.08% 188
2022
Q4
$2.26M Buy
10,979
+23
+0.2% +$5.82K 0.06% 209
2022
Q3
$3.05M Buy
+10,956
New +$2.79M 0.16% 116

Other funds holding SWAV

BI Asset Management Fondsmaeglerselskab's SWAV Position: Q2 2024 in Review

BI Asset Management Fondsmaeglerselskab sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 368 shares — an estimated $120K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in SWAV in Q3 2022 and held it in 5 quarters. The position peaked at $3.05M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 368 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $120K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • BI Asset Management Fondsmaeglerselskab's Shockwave Medical, Inc. Common Stock position peaked at $3.05M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2024, filed 14 Aug 2024.